AG真人官方

ZoomInfo Technologies Inc. (ZI) 鈥� Form 144 filing discloses a planned insider sale under Rule 144.

• Securities to be sold: 14,773 Class A common shares.
• Estimated market value: US$148,911.84 (based on prevailing market price cited in the form).
• Seller of record: James M. Roth, acting pursuant to a Rule 10b5-1 trading plan, with Morgan Stanley Smith Barney LLC as broker.
• Planned sale date: on or about 02 July 2025 through NASDAQ.
• Share-count context: ZI reports 328,911,200 shares outstanding; the proposed sale represents 鈮�0.0045 % of shares outstanding.
• Recent activity: The same insider sold 18,408 shares on 05 June 2025 for gross proceeds of US$184,398.72.

The filing is a routine notice rather than a completed transaction. Given the small size relative to total float, the event is unlikely to be materially impactful for shareholders, but it does provide visibility into insider trading activity and possible sentiment.

GitLab Inc. (NASDAQ: GTLB) has filed a Form 144 disclosing the proposed sale of 1,214 shares of its Class A common stock under Rule 144. The shares, valued at roughly $55,249, account for less than 0.001 % of the company鈥檚 approximately 146.1 million shares outstanding, making the transaction immaterial to GitLab鈥檚 overall float and market liquidity.

The seller acquired the stock as restricted stock units (RSUs) on 27 June 2025 and intends to execute the sale through Morgan Stanley Smith Barney LLC on or after 2 July 2025. No additional sales by this filer have occurred in the past three months. The notice states that the filer is unaware of any non-public adverse information, suggesting this is a routine liquidity event rather than a signal of strategic change.

Paymentus Holdings, Inc. (PAY) has filed a Form 4 disclosing that its Chairman, President & CEO, Dushyant Sharma, received 1,100,000 Class A RSUs on 07/02/2025 under the company鈥檚 2021 Equity Incentive Plan. Each RSU converts into one share of Class A common stock as it vests. Vesting schedule: one-sixteenth of the award will vest on each quarterly vesting date beginning 15 Aug 2025 (Feb 15, May 15, Aug 15, Nov 15 thereafter), subject to continued service. Following the grant, the reporting person shows 1,100,000 shares owned directly and an additional 1 share held indirectly through Ashigrace LLC, where Sharma holds sole voting and dispositive power. No price was paid for the RSUs, indicating a standard equity-based compensation grant designed to align executive incentives with shareholder value over time.

Paymentus Holdings, Inc. (PAY) has filed a Form 4 disclosing that its Chairman, President & CEO, Dushyant Sharma, received 1,100,000 Class A RSUs on 07/02/2025 under the company鈥檚 2021 Equity Incentive Plan. Each RSU converts into one share of Class A common stock as it vests. Vesting schedule: one-sixteenth of the award will vest on each quarterly vesting date beginning 15 Aug 2025 (Feb 15, May 15, Aug 15, Nov 15 thereafter), subject to continued service. Following the grant, the reporting person shows 1,100,000 shares owned directly and an additional 1 share held indirectly through Ashigrace LLC, where Sharma holds sole voting and dispositive power. No price was paid for the RSUs, indicating a standard equity-based compensation grant designed to align executive incentives with shareholder value over time.

UBS AG is offering Contingent Income Auto-Callable Securities linked to the common stock of PayPal Holdings, Inc. (PYPL). The notes are senior unsecured obligations of UBS AG London Branch, priced at $1,000 per security, with expected issuance on 16 July 2025 and maturity on or about 14 July 2028 (鈮�36 months).

Coupon mechanics: investors receive a fixed contingent payment of $27.875 per quarter (鈮�11.15 % p.a.) for any determination date on which PYPL鈥檚 closing price is at least 65 % of the initial price (鈥渄ownside threshold鈥�). If, on any determination date other than the final one, PYPL closes at or above 100 % of the initial price (鈥渃all threshold鈥�), the notes are automatically redeemed for $1,000 + the current coupon.

Principal repayment: 鈥� If the final price on 11 July 2028 is 鈮�65 % of the initial price, holders receive principal plus the final coupon. 鈥� If it is <65 %, UBS will pay a cash value equal to the percentage decline in PYPL, exposing investors to a 1-for-1 loss below the threshold and up to 100 % loss of principal. There is no upside participation in PYPL shares.

Key economics & costs: 鈥� Estimated initial value: $937.30 鈥� $967.30 (3.3 %-6.3 % below issue price), reflecting dealer margins, hedging and funding costs. 鈥� Up-front fees total 2.25 % of principal (1.75 % sales commission, 0.50 % structuring fee). 鈥� Securities will not be listed; UBS Securities LLC intends, but is not obligated, to provide a secondary market.

Risk highlights: investors face (i) issuer credit risk of UBS AG, (ii) equity risk in PYPL, (iii) liquidity risk given the unlisted nature, (iv) early-call reinvestment risk, and (v) tax uncertainty; the notes are treated as prepaid derivatives with ordinary-income coupons.

Investor profile: suitable only for sophisticated investors who can tolerate loss of principal, limited upside, and illiquidity in exchange for above-market contingent income.

Form 4 filing for Y-mAbs Therapeutics (YMAB) discloses that director Laura Hamill received new equity awards on 30 June 2025.

• Restricted Stock Units: 25,080 RSUs granted at no cost. The award vests in full on the earlier of 12 months after grant or immediately before the 2026 annual shareholder meeting, subject to continued service.
• Stock Options: 33,450 options with a US$4.51 exercise price, expiring 30 June 2035. Vest in equal monthly instalments over one year and become exercisable upon vesting.
• Post-transaction ownership: Hamill now directly holds 30,905 YMAB common shares and 33,450 vested/unvested options.

The transactions reflect routine director compensation under the 2018 Equity Incentive Plan and do not involve open-market purchases or sales.

Fiserv, Inc. (symbol FI) has filed a Form 25 with the U.S. Securities and Exchange Commission to remove its 2.250% Senior Notes due 2025 from listing and registration on the New York Stock Exchange (NYSE) under Section 12(b) of the Exchange Act. The NYSE certifies that it has met all requirements for striking the securities and that the issuer has complied with exchange and SEC Rule 12d2-2 procedures for voluntary withdrawal. The notification was signed on 1 July 2025 by an authorized NYSE representative. The filing affects only this specific debt class and does not reference Fiserv鈥檚 common equity or operational metrics.

Nayax Ltd. (Symbol: NYAX) filed a Form 144 indicating a proposed insider sale of ordinary shares. The filing covers 100,000 ordinary shares to be sold through Oppenheimer & Co. Inc. on or about 18 June 2025 on Nasdaq. At the stated aggregate market value of $4.49 million, the proposed transaction represents roughly 2.2 % of the 4,593,000 shares outstanding reported in the form.

The securities were originally acquired on 16 Jan 2005 as 鈥渇ounder shares鈥� purchased from the issuer for cash. The filer鈥檚 name鈥攕hown in the recent-sales table as 鈥淎mir Nechmad / Nechmad Amir Alimelech鈥�鈥攕uggests an individual with founding status, although the 鈥淩elationship to Issuer鈥� field was left blank.

Recent selling activity:

• 23 Apr 2025: 1,773 shares sold for $73,290.38
• 24 Apr 2025: 1,800 shares sold for $74,145.35
• 05 May 2025: 91,791 shares sold for $3.87 million
• 02 Jun 2025: 140,602 shares sold for $6.50 million

Including the proposed 100,000-share sale, the insider either has sold or plans to sell 鈮�335,000 shares within a four-month window, generating (or expected to generate) total proceeds of roughly $15.4 million.

The filer certifies that no undisclosed material adverse information is known and affirms compliance with Rule 144 disclosure requirements.